在分子分类时代用于子宫内膜癌的辅助疗法
Sumedha Gupta1, Ratika Gupta2, Varsha Motwani1
1Department of Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Journal of mid-life health
|November 29, 2024
概括
对子宫内膜癌的辅助治疗以风险因素为指导,分子亚型越来越多地为个性化策略提供信息. 研究正在转向综合诊断和向治疗,以改善患者的治疗结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子瘤学分子瘤学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 子宫内膜癌的治疗依赖于手术和辅助疗法,如放射治疗和化疗.
- 治疗选择是基于临床病理风险因素.
- 新兴的分子分类为疾病行为提供了更深入的见解.
研究的目的:
- 审查目前对子宫内膜癌的辅助治疗策略.
- 突出分子分析在风险分层中的日益重要的重要性.
- 讨论子宫内膜癌向治疗的进展.
主要方法:
- 对调查辅助治疗的随机试验的审查.
- 对影响治疗决策的临床病理因素的分析.
- 检查分子研究的发现,包括癌症基因组图谱项目.
主要成果:
- 辅助性阴道支臂疗法可以改善高中风险病例的局部控制.
- 对于高风险的I-II期瘤,建议进行盆腔放射治疗.
- 化学辐射可以提高血清性癌症和III期疾病的存活率.
- 已经确定了四种不同的子宫内膜癌分子亚型,显示出显著的预后价值.
结论:
- 分子亚型提供比传统遗传病理学更准确的预后.
- 转向分子综合诊断和个性化辅助疗法的范式转变正在进行中.
- 向治疗是子宫内膜癌管理的有希望的未来方向.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


